We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$51.9K
2
OVV icon
Ovintiv
OVV
+$14.7K
3
VANI icon
Vivani Medical
VANI
+$119

Top Sells

Rank Stock Value
1
BIP icon
Brookfield Infrastructure Partners
BIP
+$78.8K
2
TU icon
Telus
TU
+$37K
3
ODFL icon
Old Dominion Freight Line
ODFL
+$14.5K
4
BBBY
Bed Bath & Beyond
BBBY
+$11

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LILA icon
2501
Liberty Latin America Class A
LILA
$1.63B
$0 ﹤0.01%
45
– –
LIVN icon
2502
LivaNova
LIVN
$4.4B
$0 ﹤0.01%
12
– –
LMNR icon
2503
Limoneira
LMNR
$237M
$0 ﹤0.01%
48
– –
MDXG icon
2504
MiMedx Group
MDXG
$580M
$0 ﹤0.01%
41
– –
KG
2505
Kestrel Group
KG
$67.1M
$0 ﹤0.01%
13
– –
MSGS icon
2506
Madison Square Garden
MSGS
$9.51B
$0 ﹤0.01%
4
– –
MUX icon
2507
McEwen Inc
MUX
$1B
$0 ﹤0.01%
20
– –
NGD
2508
DELISTED
New Gold Inc
NGD
$0 ﹤0.01%
272
– –
NWG icon
2509
NatWest
NWG
$75B
$0 ﹤0.01%
8
– –
OMER icon
2510
Omeros
OMER
$827M
$0 ﹤0.01%
37
– –
PJT icon
2511
PJT Partners
PJT
$4.35B
$0 ﹤0.01%
10
– –
QRVO icon
2512
Qorvo
QRVO
$7.9B
$0 ﹤0.01%
3
– –
RARE icon
2513
Ultragenyx Pharmaceutical
RARE
$2.44B
$0 ﹤0.01%
14
– –
RMR icon
2514
The RMR Group
RMR
$326M
$0 ﹤0.01%
1
– –
ROKU icon
2515
Roku
ROKU
$21.5B
$0 ﹤0.01%
7
– –
RYAM icon
2516
Rayonier Advanced Materials
RYAM
$587M
$0 ﹤0.01%
254
– –
RZB
2517
DELISTED
Reinsurance Group of America 5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056
RZB
$0 ﹤0.01%
6
– –
SAGE
2518
DELISTED
Sage Therapeutics
SAGE
$0 ﹤0.01%
5
– –
SBGI icon
2519
Sinclair Inc
SBGI
$971M
$0 ﹤0.01%
14
– –
SITC icon
2520
SITE Centers
SITC
$224M
$0 ﹤0.01%
70
– –
SOHU
2521
Sohu.com
SOHU
$350M
$0 ﹤0.01%
31
– –
SPH icon
2522
Suburban Propane Partners
SPH
$1.23B
$0 ﹤0.01%
13
– –
SUP
2523
DELISTED
Superior Industries International
SUP
$0 ﹤0.01%
147
– –
SWBI icon
2524
Smith & Wesson
SWBI
$654M
$0 ﹤0.01%
78
– –
TLRY icon
2525
Tilray
TLRY
$569M
$0 ﹤0.01%
3
– –
99 100
101
102 103

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.